Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AmberHealth vs Ozari Health

AmberHealth
Site position #24

Higher grade

vs+14
Ozari Health
Site position #153

Lower grade

The verdict

AmberHealth takes it — 82.9/100 to 68.9/100.

AmberHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide nationwide, though tirzepatide runs $175 and it isn't verified.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAmberHealth +15
90
75
Dose & formulationAmberHealth +16
80
64
Clinical oversightEven
79
79
Labs & monitoringAmberHealth +26
78
52
FulfillmentAmberHealth +3
86
83
Contract termsAmberHealth +35
82
47
AmberHealth · left barOzari Health · right bar

The numbers

MetricAmberHealthOzari Health
WeighScore82.9/10068.9/100
GradeB−C
Site position#24#153
Semaglutide$100/mo$86/mo (3-mo starter plan, new patients only, compounded)
Tirzepatide$175/mo$125/mo (3-mo starter plan, new patients only, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
AmberHealth

Site position #24 · B−

Strengths

  • $100 semaglutide
  • All 50 states
  • Both molecules

Where it loses points

  • Independent LegitScript certification has not been verified for this review
  • Tirzepatide $175
  • Monitoring detail sparse
Ozari Health

Site position #153 · C

Strengths

  • Very low entry pricing — compounded semaglutide from $86/month
  • LegitScript certified and operated by a named entity (Ozari LLC)
  • Board-certified physicians; meds compounded in 503A and 503B facilities
  • Shipping included in the plan price

Where it loses points

  • The advertised rates are three-month starter plans for first-time GLP-1 users, billed $257 and $375 up front; month-to-month is $175 and $235
  • Canceling an annual or semi-annual plan early re-prices the installments already shipped at the standard monthly rate and charges the difference
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard